Search for: "Axcan"
Axcan Licenses Rights to Cx401, an Innovative Biological Product in Development for the Treatment of Perianal Fistulas, a Significant Unmet Medical Need
HSMN NewsFeed,
1 Oct 2007:
Biopharmaceuticals, Regenerative Medicine
[Axcan Pharma, Cellerix, Cx401, perianal fistulas, stem cell]
|
Axcan Pharma Submits Complete New Drug Application for ULTRASE
HSMN NewsFeed,
2 Aug 2007:
Biopharmaceuticals, Gastroenterology
[Axcan Pharma, ULTRASE, Exocrine Pancreatic Insufficiency]
|
Axcan Pharma Initiates MAX-002 Phase III Clinical Trial to Evaluate the Efficacy and Safety of a High-Concentration 1 Gram Mesalamine Suppository
HSMN NewsFeed,
14 Jun 2007:
Biopharmaceuticals
[Axcan Pharma, MAX-002, CANASA, mesalamine, ulcerative proctitis]
|
Axcan Announces the U.S. Launch of PYLERA, an Innovative 3-in-1 Capsule Triple Therapy for the Eradication of Helicobacter Pylori
HSMN NewsFeed,
7 May 2007:
Biopharmaceuticals, Gastroenterology
[Axcan Pharma, PYLERA, Helicobacter pylori, gastric ulcer, duodenal ulcer]
|
Axcan Receives FDA Approval Letter for PYLERA'TM' -Formerly Known as HELIZIDE-, an Innovative 3-in-1 Capsule Triple Therapy for the Eradication of Helicobacter Pylori
HSMN NewsFeed,
29 Sep 2006:
Biopharmaceuticals, Gastroenterology, FDA
[Axcan Pharma, PYLERA , HELIZIDE , Helicobacter pylori]
|
Axcan and AGI Therapeutics Sign Exclusive License and Co-Development Agreement for the Next-Generation Therapy for GERD and the Control of Nocturnal Acid Breakthrough
HSMN NewsFeed,
26 Sep 2006:
Biopharmaceuticals, Gastroenterology, Licensing
[Axcan Pharma, AGI Therapeutics, CHRONAB omeprazole, AGI-010, omeprazole]
|
Axcan Pharma appoints new Senior Vice President and Chief Scientific Officer
HSMN NewsFeed,
10 May 2006:
Biopharmaceuticals, Personnel
[AXCAN PHARMA]
|
Axcan submits FDA amendment to its new drug application for HELIZIDE
HSMN NewsFeed,
29 Mar 2006:
Biopharmaceuticals, Gastroenterology, FDA
[AXCAN PHARMA, HELIZIDE, Helicobacter pylori]
|
Axcan announces outcome of ITAX International Phase III clinical trial
HSMN NewsFeed,
22 Feb 2006:
Biopharmaceuticals, Gastroenterology
[Axcan Pharma, ITAX , Itopride, Functional Dyspepsia]
|
Axcan Appoints Steve Gannon Senior Vice President and Chief Financial Officer
HSMN NewsFeed,
20 Jan 2006:
Biopharmaceuticals, Personnel
[AXCAN PHARMA]
|
|
|
Public
Feeds 
Full text >>
